SBC
SBC Medical Group Holdings IncPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| EBITDA non-GAAP | $18M | Q1 2026 | — |
| EBITDA margin non-GAAP | 43% | Q1 2026 | — |
| Number of customers in the last twelve months ended March 31, 2026 | 6.76M | last twelve months ended March 31, 2026 | — |
| Number of franchise locations | 284 | as of March 31, 2026 | — |
| Return on equity | 18% | Q1 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Consulting Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SBC
this stock
SBC Medical Group Holdings Inc
|
$304.43M | -31.3% | -15.5% | 7.4 | 0.4% |
|
VRSK
Verisk Analytics, Inc.
|
$25.19B | -13.8% | +6.6% | 29.3 | 6.7% |
|
EFX
Equifax Inc
|
$19.90B | -22.8% | +6.9% | 29.4 | 4.8% |
|
BAH
Booz Allen Hamilton Holding Corp
|
$7.58B | -24.4% | -6.4% | 9.2 | 6.4% |
|
FCN
Fti Consulting, Inc
|
$4.71B | -8.5% | +15.2% | 18.6 | 6.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SBC | -6.0% | -1.7% | -33.8% | -3.9% | -31.3% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -6.9% | -3.0% | -41.3% | -4.0% | -41.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.